MITA Paediatric 500 mg/100 ml
Generic: Butamirate Citrate
Category: Oral Drops
Manufacturer: Ad-din Pharmaceuticals Ltd.
Allopathic
MFG. Licence No. Biological
202
MFG. Licence No. Non-Biological
053
Address
BSCIC Industrial Estate,Jhumjumpur, Jessore
Price: 45.0 ৳
15 ml x 0 in Bottle
Medicine Selling service is not available yet.
Alternative Brands & Related Medicines
Indications
Cough (non-productive), Whooping cough, Pre-post operative cough, Cough suppression
Hypersensitivity.
Therapeutic Class
Cough suppressant
Pharmacology
Butamirate Citrate belongs to the anti-cough medicines of central action. It exerts expectorant, moderate bronchodilating and anti-inflammatory action. Butamirate Citrate also increases the spirometery indexes and blood oxygenation. It is safe and non-sedating which is neither chemically nor pharmacologically related to opium alkaloids. The active metabolites of Butamirate Citrate have also antitussive action.
Dosage and Administration
Adult Dose:
Tablet: Adolescents over 12 years old: 1-2 tablets daily.
Adults: 2-3 tablets daily at 8 to 12 hours intervals.
Syrup: Adult: 15 ml 4 times daily; Adolescent: 15 ml 4 times daily
Child Dose:
Tablet:
Adolescents over 12 years old: 1-2 tablets daily.
Syrup:
Children (6-12 years): 10 ml 3 times daily,
Children (3-6 years): 5 ml 3 times daily.
Paediatric drops:
Infants (2 months - 1 year): 10 drops four times daily;
Infants (1 - 3 years): 15 drops four times daily.
Interaction
Concomitant use of expectorants may lead to retention of mucous in the resp system, which can increase the risk of bronchospasm and airway infection.
Contraindications
Hypersensitivity.
Side Effects
Rarely, skin rash, nausea, diarrhoea or dizziness.
Pregnancy And Lactation
Butamirate Citrate should not be used during the first trimester of pregnancy. During the remainder of pregnancy, it can be used if indicated by a physician but with caution. As a general rule, for safety reasons, in the absence of data on elimination of the active substance in breast milk, the benefits of Butamirate Citrate administration during breast feeding should be carefully weighed against the risks.
Precautions And Warnings
Precaution:
Pregnancy and lactation.
Overdose Effects
Accidental overdose with Butamirate Citrate can cause the following symptoms: drowsiness, nausea, vomiting, diarrhoea, loss of balance and hypotension. Standard emergency procedures should be followed: activated charcoal, saline laxatives and standard cardio-respiratory resuscitation.
Storage Conditions
Keep away from light and moisture, store below 30°C. Keep all the medicines out of the reach of children.
Drug Classes
Cough suppressant
Mode of Action
Butamirate is reported to have a central action that is used as a cough suppressant in non-productive cough.
Pregnancy Category
Butamirate Citrate should not be used during the first trimester of pregnancy. During the remainder of pregnancy, it can be used if indicated by a physician but with caution. As a general rule, for safety reasons, in the absence of data on elimination of the active substance in breast milk, the benefits of Butamirate Citrate administration during breast feeding should be carefully weighed against the risks.
Samm Care